Result Interpretation
The assessment of the ROTEM® analysis is carried out along the time axis (from left to right):
A disturbed activation of coagulation is indicated
by a prolonged clotting time. As causes, a factor deficiency or a heparin effect have to be considered. The comparison of INTEM and HEPTEM allows for a specific detection of a heparin effect.
An abnormal clot formation is indicated by a prolonged clot formation time (CFT) and/or a reduced clot firmness (MCF). The CFT is thereby
influenced more strongly by a clot polymerisation disorder than the MCF. A prolonged CFT, with at the same time normal MCF, indicates therefore
a polymerisation disorder, whereas a reduced MCF with a normal CFT rather indicates a deficiency of clottable substrate (fibrinogen and / or
platelets).
Fibrinolysis is detected by the lysis of the clot (ML > 15%) or by the finding of a better clot formation (shorter CFT, greater MCF) in APTEM as compared to EXTEM. Several centres already use, in massive bleeding, a shortening of the CT in APTEM, as compared to EXTEM, as a trigger for an antifibrinolytic drug administration.
In summary the ROTEM® analysis provides:
- Rapid information from the beginning of clot formation until its dissolution
- Concentration and activity of coagulation factors (incl. F XIII)
- Effects of anticoagulants like heparin or hirudin
- Fibrin generation and stabilisation
- Contribution of other drugs (e.g. plasma
expanders)
- Platelet count and quality
- The balance between plasmatic and platelet
derived contributions to haemostasis
- (Hyper-) fibrinolysis